SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-166080
Filing Date
2017-05-10
Accepted
2017-05-10 17:13:03
Documents
3
Period of Report
2017-05-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d382437d8k.htm 8-K 18005
2 EX-3.1 d382437dex31.htm EX-3.1 27066
3 EX-3.2 d382437dex32.htm EX-3.2 163948
  Complete submission text file 0001193125-17-166080.txt   210187
Mailing Address 205 EAST 42ND STREET SUITE 15-048 NEW YORK NY 10017
Business Address 205 EAST 42ND STREET SUITE 15-048 NEW YORK NY 10017 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38085 | Film No.: 17831492
SIC: 2834 Pharmaceutical Preparations